Thorne Healthtech, Inc. (THRN) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
620 OMNI INDUSTRIAL BLVD. SUMMERVILLE, SC 29483 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 6/30/2023 MRQ | 12/31/2022 | 12/31/2021 | |||
|---|---|---|---|---|---|
| ASSETS | |||||
| Current Assets | |||||
| Cash, cash equivalents, and short-term investments | 36,025 | 51,101 | |||
| Cash and cash equivalents | 36,025 | 51,101 | |||
| Restricted cash and investments | 4,900 | ||||
| Receivables | 14,437 | 5,652 | |||
| Inventory, net of allowances, customer advances and progress billings | 58,644 | 41,012 | |||
| Inventory | 58,644 | 41,012 | |||
| Intangible current assets | |||||
| Other undisclosed current assets | 2,616 | 3,494 | |||
| Total current assets: | 116,621 | 101,259 | |||
| Noncurrent Assets | |||||
| Finance lease, right-of-use asset, after accumulated amortization | 3,144 | 883 | |||
| Operating lease, right-of-use asset | 17,546 | 17,837 | |||
| Property, plant and equipment | 49,177 | 27,030 | |||
| Long-term investments and receivables | 1,554 | 400 | |||
| Due from related parties | 154 | ||||
| Long-term investments | 1,400 | 400 | |||
| Intangible assets, net (including goodwill) | 31,871 | 21,033 | |||
| Goodwill | 20,041 | 14,441 | |||
| Intangible assets, net (excluding goodwill) | 11,830 | 6,592 | |||
| Deferred income tax assets | 7,782 | ||||
| Other noncurrent assets | 1,167 | 994 | |||
| Other undisclosed noncurrent assets | 943 | 5,864 | |||
| Total noncurrent assets: | 113,183 | 74,040 | |||
| TOTAL ASSETS: | 229,804 | 175,300 | |||
| LIABILITIES AND EQUITY | |||||
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 30,561 | 20,561 | |||
| Employee-related liabilities | ✕ | ✕ | 2,527 | ||
| Accounts payable | 26,997 | 16,890 | |||
| Accrued liabilities | 3,564 | 1,145 | |||
| Debt | 2,184 | 908 | |||
| Other liabilities | 1,400 | ||||
| Due to related parties | 989 | 1,635 | |||
| Other undisclosed current liabilities | 5,828 | 1,233 | |||
| Total current liabilities: | 39,561 | 25,737 | |||
| Noncurrent Liabilities | |||||
| Long-term debt and lease obligation | 14,101 | 29,172 | |||
| Long-term debt, excluding current maturities | 12,646 | 1,084 | |||
| Finance lease, liability | 1,455 | 483 | |||
| Liabilities, other than long-term debt | 29,490 | 2,059 | |||
| Operating lease, liability | 28,430 | 27,606 | |||
| Derivative instruments and hedges, liabilities | 1,059 | 2,059 | |||
| Other undisclosed noncurrent liabilities | |||||
| Total noncurrent liabilities: | 43,591 | 31,230 | |||
| Total liabilities: | 83,152 | 56,967 | |||
| Equity | |||||
| Equity, attributable to parent | 144,456 | 118,006 | |||
| Common stock | |||||
| Treasury stock, value | (10) | ||||
| Additional paid in capital | 260,978 | 250,164 | |||
| Accumulated other comprehensive loss | (29) | ||||
| Accumulated deficit | (116,484) | (132,158) | |||
| Equity, attributable to noncontrolling interest | 1,661 | (199) | |||
| Other undisclosed equity | 535 | 526 | |||
| Total equity: | 146,652 | 118,332 | |||
| TOTAL LIABILITIES AND EQUITY: | 229,804 | 175,300 | |||
Income Statement (P&L) ($ in thousands)
| 6/30/2023 TTM | 12/31/2022 | 12/31/2021 | ||
|---|---|---|---|---|
| Revenues | 228,731 | 185,246 | ||
| Cost of revenue | (113,797) | (87,893) | ||
| Gross profit: | 114,934 | 97,353 | ||
| Operating expenses | (83,010) | (60,849) | ||
| Other undisclosed operating loss | (26,443) | (26,752) | ||
| Operating income: | 5,481 | 9,752 | ||
| Nonoperating income | 2,316 | 1,169 | ||
| Other nonoperating income | 1,343 | 249 | ||
| Interest and debt expense | (109) | |||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 109 | |||
| Income from continuing operations before equity method investments, income taxes: | 7,797 | 10,921 | ||
| Other undisclosed income from continuing operations before income taxes | ||||
| Income from continuing operations before income taxes: | 7,797 | 10,921 | ||
| Income tax expense (benefit) | 7,310 | (412) | ||
| Income from continuing operations: | 15,107 | 10,509 | ||
| Income before gain (loss) on sale of properties: | ✕ | 10,509 | ||
| Other undisclosed net loss | (174) | (3,664) | ||
| Net income: | 14,933 | 6,845 | ||
| Net income attributable to noncontrolling interest | 741 | 409 | ||
| Net income attributable to parent: | 15,674 | 7,253 | ||
| Undistributed earnings (loss) allocated to participating securities, basic | (3,508) | |||
| Net income available to common stockholders, basic: | 15,674 | 3,746 | ||
| Dilutive securities, effect on basic earnings per share | (396) | |||
| Net income available to common stockholders, diluted: | 15,674 | 3,349 | ||
Comprehensive Income ($ in thousands)
| 6/30/2023 TTM | 12/31/2022 | 12/31/2021 | ||
|---|---|---|---|---|
| Net income: | 14,933 | 6,845 | ||
| Other comprehensive income (loss) | (29) | |||
| Comprehensive income: | 14,904 | 6,845 | ||
| Comprehensive income, net of tax, attributable to noncontrolling interest | 741 | 409 | ||
| Comprehensive income, net of tax, attributable to parent: | 15,645 | 7,253 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.